Morgan Stanley Maintains Gilead at Overweight, Raises Target to $183
Morgan Stanley raised its price target from $163 to $183 while maintaining its Overweight rating.
Morgan Stanley raised its price target from $163 to $183 while maintaining its Overweight rating.